Roflumilast and cognition enhancement: A translational perspective

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Cognitive impairment significantly impacts daily life and quality of life for patients with neurological disorders, imposing substantial health, social, and financial burdens.
• Current treatments for cognitive impairment, primarily for Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI), have significant adverse effects.
• Roflumilast, a selective phosphodiesterase type 4 (PDE4) inhibitor approved for COPD, has demonstrated potential for cognitive enhancement.

Purpose of the Study:

• To evaluate the pro-cognitive and anti-inflammatory effects of roflumilast in nonclinical and clinical settings.
• To assess the safety and tolerability of roflumilast at doses relevant for cognitive enhancement.
• To explore the potential repurposing of roflumilast as an affordable treatment for cognitive impairments in various Central Nervous System (CNS) diseases.

Main Methods:

• Nonclinical studies in rodents and animal models of CNS disorders to assess roflumilast's effects on cognition.
• Clinical studies in healthy adults, elderly individuals, MCI patients, and schizophrenia patients to evaluate cognition enhancement at low doses (100-250 µg).
• Ongoing clinical trials investigating pro-cognitive effects in early AD, post-stroke cognitive impairment, and Fragile X.

Main Results:

• Nonclinical studies indicated dose-dependent pro-neuroplasticity and anti-inflammatory effects of roflumilast.
• Clinical studies demonstrated cognition enhancement in healthy adults, elderly, MCI patients, and schizophrenia patients at low, well-tolerated doses.
• Roflumilast was found to be well-tolerated at doses (100-250 µg) that improved cognitive performance.

Conclusions:

• Roflumilast exhibits beneficial effects on cognitive performance across various populations and CNS conditions.
• The favorable therapeutic window and well-tolerated nature of roflumilast at low doses support its potential for cognitive enhancement.
• Repurposing roflumilast may offer an affordable and effective treatment option for patients suffering from cognitive impairments due to neurological disorders.